| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyCellularComponent | endoplasmic reticulum quality control compartment | 1.85e-04 | 17 | 25 | 2 | GO:0044322 | |
| Domain | ARHGEF5_35 | 2.01e-06 | 2 | 27 | 2 | PF15441 | |
| Domain | ARHGEF5/35_N | 2.01e-06 | 2 | 27 | 2 | IPR029212 | |
| Domain | - | 6.03e-06 | 3 | 27 | 2 | 2.10.250.10 | |
| Domain | CALRETICULIN_REPEAT | 6.03e-06 | 3 | 27 | 2 | PS00805 | |
| Domain | Calret/calnex | 1.21e-05 | 4 | 27 | 2 | IPR001580 | |
| Domain | Calreticulin | 1.21e-05 | 4 | 27 | 2 | PF00262 | |
| Domain | CALRETICULIN_1 | 1.21e-05 | 4 | 27 | 2 | PS00803 | |
| Domain | CALRETICULIN_2 | 1.21e-05 | 4 | 27 | 2 | PS00804 | |
| Domain | Calret/calnex_CS | 1.21e-05 | 4 | 27 | 2 | IPR018124 | |
| Domain | Calreticulin/calnexin_P_dom | 2.01e-05 | 5 | 27 | 2 | IPR009033 | |
| Domain | SANT | 2.36e-03 | 50 | 27 | 2 | SM00717 | |
| Domain | SANT/Myb | 2.55e-03 | 52 | 27 | 2 | IPR001005 | |
| Domain | SCAN | 2.95e-03 | 56 | 27 | 2 | SM00431 | |
| Domain | SCAN_BOX | 3.16e-03 | 58 | 27 | 2 | PS50804 | |
| Domain | SCAN | 3.16e-03 | 58 | 27 | 2 | PF02023 | |
| Domain | SCAN_dom | 3.16e-03 | 58 | 27 | 2 | IPR003309 | |
| Domain | Retrov_capsid_C | 3.27e-03 | 59 | 27 | 2 | IPR008916 | |
| Domain | - | 8.27e-03 | 95 | 27 | 2 | 2.60.120.200 | |
| Pathway | REACTOME_CALNEXIN_CALRETICULIN_CYCLE | 4.00e-05 | 7 | 20 | 2 | MM15592 | |
| Pathway | REACTOME_N_GLYCAN_TRIMMING_IN_THE_ER_AND_CALNEXIN_CALRETICULIN_CYCLE | 1.99e-04 | 15 | 20 | 2 | MM15175 | |
| Pathway | BIOCARTA_EIF_PATHWAY | 2.27e-04 | 16 | 20 | 2 | M7721 | |
| Pathway | REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC | 5.63e-04 | 25 | 20 | 2 | MM15713 | |
| Pathway | REACTOME_CALNEXIN_CALRETICULIN_CYCLE | 6.09e-04 | 26 | 20 | 2 | M907 | |
| Pathway | REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC | 7.59e-04 | 29 | 20 | 2 | M1062 | |
| Pathway | REACTOME_N_GLYCAN_TRIMMING_IN_THE_ER_AND_CALNEXIN_CALRETICULIN_CYCLE | 1.11e-03 | 35 | 20 | 2 | M918 | |
| Pubmed | Beyond lectins: the calnexin/calreticulin chaperone system of the endoplasmic reticulum. | 6.25e-07 | 2 | 28 | 2 | 16467570 | |
| Pubmed | Calreticulin is required for development of the cumulus oocyte complex and female fertility. | 6.25e-07 | 2 | 28 | 2 | 26388295 | |
| Pubmed | Compromised calnexin function in calreticulin-deficient cells. | 6.25e-07 | 2 | 28 | 2 | 12727205 | |
| Pubmed | Contrasting functions of calreticulin and calnexin in glycoprotein folding and ER quality control. | 6.25e-07 | 2 | 28 | 2 | 14731400 | |
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 14732231 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 17708944 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 8550632 | ||
| Pubmed | 1.81e-06 | 257 | 28 | 5 | 31046837 | ||
| Pubmed | ER-60 domains responsible for interaction with calnexin and calreticulin. | 1.87e-06 | 3 | 28 | 2 | 15236594 | |
| Pubmed | Promotion of transferrin folding by cyclic interactions with calnexin and calreticulin. | 1.87e-06 | 3 | 28 | 2 | 9312001 | |
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 12052826 | ||
| Pubmed | The glut 1 glucose transporter interacts with calnexin and calreticulin. | 1.87e-06 | 3 | 28 | 2 | 8662691 | |
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 36224200 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 11795871 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 10364189 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 19054761 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 11765911 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 22242185 | ||
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 8910335 | ||
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 21172390 | ||
| Pubmed | Calnexin, calreticulin, and ERp57 cooperate in disulfide bond formation in human CD1d heavy chain. | 3.75e-06 | 4 | 28 | 2 | 12239218 | |
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 14980518 | ||
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 15677452 | ||
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 12383251 | ||
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 25541284 | ||
| Pubmed | A novel quality control compartment derived from the endoplasmic reticulum. | 3.75e-06 | 4 | 28 | 2 | 11408579 | |
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 18791162 | ||
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 9525969 | ||
| Pubmed | 6.24e-06 | 5 | 28 | 2 | 9746750 | ||
| Pubmed | 6.24e-06 | 5 | 28 | 2 | 20520781 | ||
| Pubmed | 6.24e-06 | 5 | 28 | 2 | 10436013 | ||
| Pubmed | 9.36e-06 | 6 | 28 | 2 | 10929008 | ||
| Pubmed | 9.36e-06 | 6 | 28 | 2 | 19524015 | ||
| Pubmed | 1.31e-05 | 7 | 28 | 2 | 11823531 | ||
| Pubmed | 1.74e-05 | 8 | 28 | 2 | 10047538 | ||
| Pubmed | Deletion of Tmtc4 activates the unfolded protein response and causes postnatal hearing loss. | 1.74e-05 | 8 | 28 | 2 | 30188326 | |
| Pubmed | 2.24e-05 | 9 | 28 | 2 | 16847323 | ||
| Pubmed | Sensitive detection of idiotypic platelet-reactive alloantibodies by an electrical protein chip. | 2.24e-05 | 9 | 28 | 2 | 22572157 | |
| Pubmed | ER-60, a chaperone with thiol-dependent reductase activity involved in MHC class I assembly. | 2.80e-05 | 10 | 28 | 2 | 9545232 | |
| Pubmed | 3.42e-05 | 11 | 28 | 2 | 17913437 | ||
| Pubmed | 4.85e-05 | 13 | 28 | 2 | 18303019 | ||
| Pubmed | 6.52e-05 | 15 | 28 | 2 | 17090218 | ||
| Pubmed | 7.45e-05 | 16 | 28 | 2 | 19943849 | ||
| Pubmed | 8.44e-05 | 17 | 28 | 2 | 32938586 | ||
| Pubmed | 1.31e-04 | 327 | 28 | 4 | 34428256 | ||
| Pubmed | Phosphorylated tau interactome in the human Alzheimer's disease brain. | 1.39e-04 | 125 | 28 | 3 | 32812023 | |
| Pubmed | Mutual regulation between OGT and XIAP to control colon cancer cell growth and invasion. | 2.24e-04 | 704 | 28 | 5 | 32994395 | |
| Pubmed | 2.26e-04 | 377 | 28 | 4 | 25147182 | ||
| Pubmed | Next-generation sequencing to generate interactome datasets. | 2.57e-04 | 1147 | 28 | 6 | 21516116 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | 2.66e-04 | 1155 | 28 | 6 | 20360068 | |
| Pubmed | 2.72e-04 | 157 | 28 | 3 | 19423573 | ||
| Pubmed | 2.86e-04 | 31 | 28 | 2 | 17215244 | ||
| Pubmed | Hepatic lipase maturation: a partial proteome of interacting factors. | 2.86e-04 | 31 | 28 | 2 | 19136429 | |
| Pubmed | The unfolded protein response: integrating stress signals through the stress sensor IRE1α. | 2.86e-04 | 31 | 28 | 2 | 22013210 | |
| Pubmed | A Role for Mitochondrial Translation in Promotion of Viability in K-Ras Mutant Cells. | 3.38e-04 | 419 | 28 | 4 | 28700943 | |
| Pubmed | 4.09e-04 | 37 | 28 | 2 | 19034380 | ||
| Pubmed | 4.71e-04 | 1285 | 28 | 6 | 35914814 | ||
| Pubmed | Agrin has a pathological role in the progression of oral cancer. | 5.28e-04 | 197 | 28 | 3 | 29872149 | |
| Pubmed | 5.79e-04 | 44 | 28 | 2 | 30886144 | ||
| Pubmed | 6.06e-04 | 45 | 28 | 2 | 1286667 | ||
| Pubmed | 6.15e-04 | 878 | 28 | 5 | 37223481 | ||
| Pubmed | Defining the Na+/H+ exchanger NHE1 interactome in triple-negative breast cancer cells. | 6.33e-04 | 46 | 28 | 2 | 27751915 | |
| Pubmed | Blocking an N-terminal acetylation-dependent protein interaction inhibits an E3 ligase. | 6.33e-04 | 495 | 28 | 4 | 28581483 | |
| Pubmed | The in vivo brain interactome of the amyloid precursor protein. | 7.48e-04 | 50 | 28 | 2 | 17934213 | |
| Pubmed | A conserved acetylation switch enables pharmacological control of tubby-like protein stability. | 7.57e-04 | 223 | 28 | 3 | 33187986 | |
| Pubmed | 7.77e-04 | 225 | 28 | 3 | 25277244 | ||
| Cytoband | 7q35 | 5.22e-04 | 55 | 28 | 2 | 7q35 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q35 | 7.51e-04 | 66 | 28 | 2 | chr7q35 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p35 | 3.18e-03 | 137 | 28 | 2 | chr1p35 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q35 | 9.03e-03 | 235 | 28 | 2 | chr5q35 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 1.55e-03 | 53 | 20 | 2 | 532 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.39e-03 | 66 | 20 | 2 | 722 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue | 1.14e-04 | 151 | 28 | 3 | 999c11d19b61d6b130ad5e623afa83cbdfe13cdd | |
| ToppCell | BAL-Mild-Myeloid-TRAM-TRAM2-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.14e-04 | 151 | 28 | 3 | 28e3f77d2edb30fcf1414762a55ceffaf879d526 | |
| ToppCell | BAL-Mild-Myeloid-TRAM-TRAM2|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.14e-04 | 151 | 28 | 3 | 688cc5e4d46ba16f9b431352d7a6d39b21941e9c | |
| ToppCell | BAL-Mild-Myeloid-TRAM-TRAM2-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.14e-04 | 151 | 28 | 3 | 45392bb1c6358beff33da0ca84f7696fb5824f30 | |
| ToppCell | BAL-Mild-Myeloid-TRAM-TRAM2|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.14e-04 | 151 | 28 | 3 | 3d861285c71abe220b19a069eb9876199c6c8f39 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.21e-04 | 154 | 28 | 3 | ec920cae12ea1d14b6c973f6e903f895f80e3c50 | |
| ToppCell | Mild_COVID-19-Myeloid-TRAM2|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 1.21e-04 | 154 | 28 | 3 | ab648f6b29eb9e499e46cbdbaf3c5cf6b94d1f64 | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-04 | 158 | 28 | 3 | d3446fc98eff09c3626b47a2c90d07cd985378b5 | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-04 | 158 | 28 | 3 | df614450e10629dc9115d7365397663e82f9e48f | |
| ToppCell | Mild-MAIT|World / Disease group and Cell class | 1.46e-04 | 164 | 28 | 3 | 21dc02997dfae73cf70ce291661928526605dba1 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.82e-04 | 177 | 28 | 3 | da8802a6351d3e510822f82e2fde8a4314a2216e | |
| ToppCell | facs-Lung-18m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.95e-04 | 181 | 28 | 3 | ebf1ae963a2b22e1772752ed85a4fb0e546d377e | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.01e-04 | 183 | 28 | 3 | 3c516fe5083f02bad1f464ed284010b4131a833c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.01e-04 | 183 | 28 | 3 | 848fc6dd129150897ee339343e83c645b6e779eb | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.01e-04 | 183 | 28 | 3 | 9c2689d76fc6d30f5ab093428aa669d0a98953cf | |
| ToppCell | Control-Neu_4|World / 5 Neutrophil clusters in COVID-19 patients | 2.04e-04 | 184 | 28 | 3 | ce7f044956613118ee2e9fb6af2455c3166cb414 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.04e-04 | 184 | 28 | 3 | 7294b379ce4cb8fa75e432559082f93cd106aaf5 | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_D3|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.08e-04 | 185 | 28 | 3 | 4a5e70ac41e5f3b25a773304ffef3c2a3dd5549d | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.08e-04 | 185 | 28 | 3 | 34fcfd635c828dad9643bbf1c908d79282d6f5d9 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.08e-04 | 185 | 28 | 3 | 8816f2909ed11833ff3d0ed96b9cb6d6fe9e1578 | |
| ToppCell | 10x5'v1-week_12-13-Hematopoietic-HSC/MPP_and_pro-CMP|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.11e-04 | 186 | 28 | 3 | 895905f1d1a01ffd5617a0baa8818693a7e9cb3b | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.18e-04 | 188 | 28 | 3 | 874404a4fd9aa42873f6c53dc42da22d3b0fdb9e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.18e-04 | 188 | 28 | 3 | b21e93a70583c30d05c0833cd3d4d4bca44a039e | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.25e-04 | 190 | 28 | 3 | b855b8b7d3439023390ca44629c1a99f5d4c6801 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.25e-04 | 190 | 28 | 3 | a5db902ad112a0c0a0a7f1a2e38718bb3bd11412 | |
| ToppCell | tumor_Lung-Myeloid_cells-CD207+CD1a+_LCs|Myeloid_cells / Location, Cell class and cell subclass | 2.25e-04 | 190 | 28 | 3 | 58a6ab70737d719ca9725ac087f20dfe9be0463e | |
| ToppCell | T_cells-Effector_memory_CD4+_T_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 2.25e-04 | 190 | 28 | 3 | 1af91fe0ee2c924e12f4db93c793e7af475d8f80 | |
| ToppCell | droplet-Pancreas-Endocrine-18m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-04 | 192 | 28 | 3 | 4510aa262da8dcf7c944b3907a51aba5a9397a4e | |
| ToppCell | 10x5'v1-week_12-13-Hematopoietic-HSC/MPP_and_pro-GMP|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.39e-04 | 194 | 28 | 3 | 02b7911d07938f04f369a552dedc614930e4396e | |
| ToppCell | Multiple_Sclerosis-Lymphocyte-T_NK-CD8_Naive|Multiple_Sclerosis / Disease, Lineage and Cell Type | 2.39e-04 | 194 | 28 | 3 | 42a9a170022f07445a7ee2577707924bbc0269db | |
| ToppCell | myeloid-CD34+_Myeloblast|World / Lineage and Cell class | 2.39e-04 | 194 | 28 | 3 | 426d5cf04e21fec2fb6ea51abd85441b2dc5c94f | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.39e-04 | 194 | 28 | 3 | 0e9830ad070c47acaa952400bf2a3ddbff664a2f | |
| ToppCell | 10x3'2.3-week_14-16-Myeloid_neutrophil-granulo-neutrophil-promyelocyte|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.46e-04 | 196 | 28 | 3 | 8ff0135e108764a3527acc00a994ced342e1cad1 | |
| ToppCell | 10x3'2.3-week_12-13-Hematopoietic-HSC/MPP_and_pro-GMP|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.46e-04 | 196 | 28 | 3 | 3cf73b33330b9fca5c8abf03f2f0d8244245b522 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.46e-04 | 196 | 28 | 3 | a9157809122e6fc5783a291522f103bef30943e4 | |
| ToppCell | 10x3'2.3-week_14-16-Hematopoietic-HSC/MPP_and_pro-GMP|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.50e-04 | 197 | 28 | 3 | 462e91dc51e363d64e1e02d7444a733838e032a5 | |
| ToppCell | 10x3'2.3-week_12-13-Myeloid_neutrophil-granulo-neutrophil-promyelocyte|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.50e-04 | 197 | 28 | 3 | 6fe4a9f67291a7e4260984e901d069ff1746d0be | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_monocytic-monocyte-MOP|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.50e-04 | 197 | 28 | 3 | 4e68a98bc7e5db7f20e865a0ca21e5a43b3cbb8f | |
| ToppCell | 10x3'2.3-week_17-19-Myeloid_neutrophil-granulo-neutrophil-promyelocyte|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.50e-04 | 197 | 28 | 3 | cfc9decbfa9ebadafda8b620ec529d3fcdd15dcd | |
| ToppCell | 10x3'2.3-week_14-16-Myeloid_monocytic-monocyte-MOP|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.50e-04 | 197 | 28 | 3 | cbfe62cd4c38ae3c893b869e8af8defb9777df25 | |
| ToppCell | Sepsis-ICU-SEP-Lymphocyte-T/NK-Treg|ICU-SEP / Disease, condition lineage and cell class | 2.50e-04 | 197 | 28 | 3 | c3ee2d522fbfe67069ddba2d1abfc4f5ca230c26 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 2.54e-04 | 198 | 28 | 3 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | mild|World / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.54e-04 | 198 | 28 | 3 | 3cef2e13d5ec71bb265171239980697a2560fa30 | |
| ToppCell | 10x3'2.3-week_17-19-Myeloid_monocytic-monocyte-MOP|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.54e-04 | 198 | 28 | 3 | f333f9ba4ac4c2c4e59dce304db20bdb8626bf07 | |
| ToppCell | 10x3'2.3-week_12-13-Myeloid_monocytic-monocyte-MOP|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.54e-04 | 198 | 28 | 3 | 3a923a2ac932fd7125f9f0836d1f06a513dc3b70 | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_A|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.54e-04 | 198 | 28 | 3 | a1c8e5c332336823c47c04e56b6d7bc8f057c9da | |
| ToppCell | 368C-Fibroblasts-Fibroblast-D-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.57e-04 | 199 | 28 | 3 | 8766796041965a1ba40ad7abdbc244bf1418c209 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-D|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.57e-04 | 199 | 28 | 3 | d39b40d84c72bdde756b805063317ecfad3784f8 | |
| ToppCell | control-CD8+_T_naive|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.57e-04 | 199 | 28 | 3 | 6a61ce7404c65e506091fee99a2001f5a9b39f31 | |
| ToppCell | 10x5'v1-week_14-16-Hematopoietic-HSC/MPP_and_pro-GMP|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.57e-04 | 199 | 28 | 3 | 030fa11c788f961cd7b21eea091c409efbf9bf24 | |
| ToppCell | MS-Multiple_Sclerosis-Lymphocyte-T/NK-CD8+_T_naive|Multiple_Sclerosis / Disease, condition lineage and cell class | 2.61e-04 | 200 | 28 | 3 | 3c919578aed30f77408a3405bce7b71bcda203e0 | |
| ToppCell | metastatic_Lymph_Node-Epithelial_cells-Malignant_cells|Epithelial_cells / Location, Cell class and cell subclass | 2.61e-04 | 200 | 28 | 3 | b16da9c342f9ff5ed4983c65b7d3b59123a594cd | |
| Drug | Doxylamine succinate [562-10-7]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 3.76e-06 | 196 | 28 | 5 | 4819_DN | |
| Drug | eV F | 1.46e-05 | 5 | 28 | 2 | CID000067944 | |
| Drug | dihydroxyaluminum aminoacetate | 2.18e-05 | 6 | 28 | 2 | ctd:C007420 | |
| Drug | zinc selenide (ZnSe | 3.05e-05 | 7 | 28 | 2 | CID000073979 | |
| Drug | AC1L1CUL | 6.52e-05 | 10 | 28 | 2 | CID000002070 | |
| Drug | Tenecteplase | 7.97e-05 | 11 | 28 | 2 | DB00031 | |
| Drug | Antihemophilic Factor | 7.97e-05 | 11 | 28 | 2 | DB00025 | |
| Drug | Betazole hydrochloride; Down 200; 27uM; HL60; HT_HG-U133A | 9.28e-05 | 196 | 28 | 4 | 1854_DN | |
| Drug | Cyclopentolate hydrochloride [5870-29-1]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 9.65e-05 | 198 | 28 | 4 | 3555_DN | |
| Drug | Pergolide mesylate [66104-23-2]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 1.00e-04 | 200 | 28 | 4 | 7031_UP | |
| Drug | EMATE | 1.73e-04 | 16 | 28 | 2 | CID000127676 | |
| Drug | cyanyl | 2.73e-04 | 20 | 28 | 2 | CID005359238 | |
| Drug | cyanogen | 3.32e-04 | 22 | 28 | 2 | CID000009999 | |
| Drug | N-nonyl-deoxygalactonojirimycin | 3.63e-04 | 23 | 28 | 2 | CID000501390 | |
| Drug | AC1L1KC5 | 4.65e-04 | 541 | 28 | 5 | CID000005428 | |
| Drug | AC1L970Z | 5.80e-04 | 29 | 28 | 2 | CID000439275 | |
| Drug | Sialic acids | 6.66e-04 | 329 | 28 | 4 | CID000349960 | |
| Drug | SureCN1562346 | 7.52e-04 | 33 | 28 | 2 | CID011646228 | |
| Disease | Osteoporosis, Senile | 1.13e-03 | 61 | 24 | 2 | C0029459 | |
| Disease | Osteoporosis, Age-Related | 1.13e-03 | 61 | 24 | 2 | C0001787 | |
| Disease | Post-Traumatic Osteoporosis | 1.13e-03 | 61 | 24 | 2 | C0751406 | |
| Disease | Osteoporosis | 1.20e-03 | 63 | 24 | 2 | C0029456 | |
| Disease | Squamous cell carcinoma of esophagus | 2.70e-03 | 95 | 24 | 2 | C0279626 | |
| Disease | Adenoid Cystic Carcinoma | 2.99e-03 | 100 | 24 | 2 | C0010606 | |
| Disease | cannabis dependence | 5.37e-03 | 135 | 24 | 2 | EFO_0007191 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 5.52e-03 | 447 | 24 | 3 | EFO_0000694, MONDO_0100096 | |
| Disease | stomach cancer (is_marker_for) | 5.92e-03 | 142 | 24 | 2 | DOID:10534 (is_marker_for) | |
| Disease | colorectal cancer (is_marker_for) | 7.19e-03 | 157 | 24 | 2 | DOID:9256 (is_marker_for) | |
| Disease | PR interval | 7.31e-03 | 495 | 24 | 3 | EFO_0004462 | |
| Disease | lung non-small cell carcinoma (is_marker_for) | 8.29e-03 | 169 | 24 | 2 | DOID:3908 (is_marker_for) | |
| Disease | Myocardial Ischemia | 8.96e-03 | 176 | 24 | 2 | C0151744 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| WNHMDEEPDNGDDRG | 46 | Q9H0P7 | |
| EGEDWEQEDEDMDPR | 251 | Q9HB65 | |
| NDIPETEVEDDEGWM | 406 | Q6UX04 | |
| SEEPGWEEEEEELMG | 216 | Q9NW68 | |
| EEEEGNEEGWVLEPQ | 56 | Q13685 | |
| EPEGLNDGEWEQEDM | 296 | Q12774 | |
| EPEGLNDGEWEQEDM | 296 | A5YM69 | |
| EDNEEPDPLPDNWEM | 296 | Q86UL8 | |
| GGPGDEWMQELDELF | 1121 | Q96JK9 | |
| PPHTMEEEEDDDWGE | 191 | P55010 | |
| WLGGLMNDDVGNEDE | 536 | Q3T8J9 | |
| EDWDEEMDGEWEPPV | 251 | P27797 | |
| DWDEDMDGEWEAPQI | 341 | P27824 | |
| EGMDPDGVIESNWNE | 16 | Q14240 | |
| PRMPQDGSDDEDEEW | 91 | Q13895 | |
| PENFLGEIEMWNEAE | 581 | A2RTX5 | |
| NGEGEPEELMVDNWR | 231 | P00918 | |
| EGKEDWEMEEDQGEE | 71 | Q9Y240 | |
| WDEDMFDEETGEGPL | 381 | P98196 | |
| EEDEEAVGAMDGWDG | 66 | Q96A61 | |
| ESPEEQEAWIQAMGE | 141 | Q9Y2H5 | |
| EMDEQEEGGWDPEEM | 436 | P17040 | |
| EEGGWDPEEMAEDCN | 441 | P17040 | |
| LQWMGEKPGEEGEED | 1086 | A6NE52 | |
| EAEPEDQDEGEWGLD | 656 | O96006 | |
| EPEDQDLWEEEGILM | 6 | O95125 | |
| EGETPGNFMEDEQWL | 31 | Q92563 | |
| GLQWVGEPMDQEDSE | 151 | Q5T124 | |
| DDGQPWGEETEDGIM | 206 | O14777 |